DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Credit Suisse Maintains Outperform on Integra Lifesciences, Lowers Price Target to $65

Credit Suisse maintains Integra Lifesciences (NASDAQ:IART) with a Outperform and lowers the price target from $70 to $65.

Benzinga · 03/06/2020 15:40

Credit Suisse maintains Integra Lifesciences (NASDAQ:IART) with a Outperform and lowers the price target from $70 to $65.